Scott Dunseth Myers's Net Worth

$4.94 Million

Estimate Recalculated Jun 3, 2024 04:39PM EST

Who is Scott Dunseth Myers?

Scott Dunseth Myers has an estimated net worth of $4.94 Million. This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., DYNAVAX TECHNOLOGIES CORP, Harpoon Therapeutics, Inc., Cartesian Therapeutics, Inc., Trillium Therapeutics Inc., AMAG PHARMACEUTICALS, INC., Viridian Therapeutics, Inc.\DE, and DOV PHARMACEUTICAL INC.

SEC CIK

Scott Dunseth Myers's CIK is 0001356256

Past Insider Trading and Trends

2023 was Scott Dunseth Myers's most active year for acquiring shares with 12 total transactions. Scott Dunseth Myers's most active month to acquire stocks was the month of April. 2018 was Scott Dunseth Myers's most active year for disposing of shares, totalling 10 transactions. Scott Dunseth Myers's most active month to dispose stocks was the month of February. 2023 saw Scott Dunseth Myers paying a total of $261,803.25 for 1,502,213 shares, this is the most they've acquired in one year. In 2023 Scott Dunseth Myers cashed out on 207,500 shares for a total of $81,375.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cascadian Therapeutics, Inc. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-56.79K
0
Mar 9
Form 4
0
0
Feb 1
Form 4
+14.22%
7.07K
$3.92
-$13,441.68
56.79K
Jan 11
Form 4
0
0
Nov 10
Form 4
0
0
Sep 18
Form 4
+12.44%
5.5K
$3.74
$20,542.50
49.72K
Aug 11
Form 4
+6.76%
2.8K
$4.00
$11,191.60
44.22K
May 12
Form 4
+5.07%
2K
$4.11
$8,228.60
41.42K
Mar 31
Form 4
+2.60%
1K
$3.93
$3,927.10
39.42K
Mar 20
Form 4
+114.42%
20.5K
$3.76
$77,039.00
38.42K
Jan 27
Form 4
0
0
Jan 11
Form 4
+72.00%
45K
$1.15
$51,745.50
107.5K
Aug 17
Form 4
62.5K
$0.80
$50,000.00
62.5K
Jun 28
Form 4
0
0
Apr 4
Form 3
0
0
No matching records found

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.915

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.67%
5.36K
25.45K
May 23
Form 4
+36.36%
5.36K
20.09K
May 26
Form 4
0
0
May 26
Form 4
0
0
Oct 19
Form 3
0
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.335

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-22.66K
0
Mar 11
Form 4
+9.93%
2.05K
22.67K
Jan 1
Form 4
+32.01%
5K
20.62K
Nov 27
Form 4
+59.03%
5.8K
15.62K
Oct 1
Form 4
+56.94%
35.63K
98.22K
Jul 1
Form 4
0
0
Jun 22
Form 4
+126.28%
34.92K
62.58K
Apr 1
Form 4
0
0
Jun 22
Form 4
0
0
Oct 25
Form 4/A
0
0
May 4
Form 4
0
0
May 4
Form 4
0
0
May 28
Form 4
0
0
Jun 3
Form 3
0
0
No matching records found

Cartesian Therapeutics, Inc. (RNAC) Snapshot price: $0.6484

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 13
Form 4
0
0
Jan 2
Form 4
0
0
Jan 3
Form 4
0
0
Mar 30
Form 4
0
0
Jun 19
Form 4
+95.11%
39.41K
$1.46
$57,537.14
80.84K
Dec 23
Form 4
41.44K
$1.81
$74,999.16
41.44K
Aug 20
Form 4
0
0
Jun 14
Form 3
0
0
No matching records found

Trillium Therapeutics Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 17
Form 4
0
0
May 3
Form 3
0
0
No matching records found